NCT07748962

Brief Summary

The purpose of this study is to learn how brain signals are related to freezing of gait (FOG) and balance problems in Parkinson's disease (PD) and to study how different deep brain stimulation (DBS) settings may affect these symptoms.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 18, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2027

Last Updated

August 6, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 27, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

Deep brain stimulationBalancePostural instabilityGait dysfunctionVirtual realityMixed realityPerceptFallsParkinson's diseaseDBS

Outcome Measures

Primary Outcomes (1)

  • Change in STN-LFP power fluctuations from single-task walking compared to FOG episode

    Participants will complete motor, cognitive and dual-task modules in a virtual reality environment that simulates a home-setting, allowing for acquisition of real-world, at-home behavior. They will also complete a stair navigation task under both single and dual-task conditions. During these assessments, neural activity (i.e., subthalamic nucleus local field potentials (STN-LFPs)) will be recorded from the Medtronic Percept Deep Brain Stimulation system. Freezing of gait (FOG) episodes will be marked by a clinician, and change in STN-LFP power fluctuations from single-task walking compared to FOG episodes will be analyzed as the primary outcome.

    Five sessions completed from enrollment to the end of testing, over an average of one week.

Secondary Outcomes (2)

  • Number of FOG episodes during the MOVE system modules under each of the four DBS conditions

    Five sessions completed from enrollment to the end of testing, over an average of one week.

  • Overall time for SAFE-Gait task

    Five sessions completed from enrollment to the end of testing, over an average of one week.

Study Arms (1)

Participants With Parkinson Disease Undergoing Multi-Condition DBS Assessments

EXPERIMENTAL

All participants undergo repeated assessments under multiple deep brain stimulation (DBS) conditions in a randomized order. Each participant serves as their own control and completes testing under clinically optimized stimulation, as well as alternative stimulation paradigms. An additional baseline condition without stimulation is performed prior to randomized testing. Assessments include walking and balance tasks performed in a virtual reality environment designed to simulate real-world gait challenges, as well as stair ambulation and functional mobility tasks. Neural activity is recorded from the implanted DBS device and synchronized with biomechanical and kinematic data collected during task performance. This design enables within-subject comparisons of neural activity and gait performance across stimulation conditions.

Other: Multiple Deep Brain Stimulation (DBS) ConditionsBehavioral: Moving Overground in a Virtual Environment (MOVE)Behavioral: Cleveland Clinic Stair Ambulation and Functional Evaluation of Gait (SAFE-Gait)

Interventions

Participants have the Medtronic Percept DBS system implanted as part of standard clinical care. During study sessions, stimulation is evaluated under different conditions, including clinically optimized stimulation, off stimulation, and alternative stimulation paradigms. Stimulation settings are temporarily adjusted for research assessments and are returned to clinically optimized settings at the end of each session. Effects of those conditions on task performance are being assessed.

Participants With Parkinson Disease Undergoing Multi-Condition DBS Assessments

Participants complete walking and balance tasks within a virtual reality environment designed to simulate real-world situations that provoke gait disturbances. Tasks include navigating environmental constraints, performing turning and stopping movements, and completing dual-task cognitive challenges while walking.

Participants With Parkinson Disease Undergoing Multi-Condition DBS Assessments

Participants complete stair ambulation and functional mobility tasks on an instrumented platform, including ascending and descending steps, walking, turning, and performing dual-task conditions. These assessments provide quantitative measures of gait performance, balance, and functional mobility.

Participants With Parkinson Disease Undergoing Multi-Condition DBS Assessments

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • You have been diagnosed with Parkinson's disease
  • You already have a deep brain stimulation (DBS) device implanted as part of your medical care - specifically, the Medtronic Percept DBS device
  • Your DBS settings have been stable for at least 3 months
  • You experience freezing of gait (sudden inability to move your feet when trying to walk)
  • You are able to walk on your own for at least 10 minutes without assistance
  • You are willing to temporarily stop your Parkinson's medications and have your DBS settings adjusted for study testing
  • You are able to understand the study and provide consent to participate

You may not qualify if:

  • You have a neurological condition other than Parkinson's disease (such as stroke or multiple sclerosis)
  • You have been diagnosed with dementia or have difficulty understanding the study or giving consent
  • You currently have alcohol or substance abuse problems
  • You have hearing or vision problems that would make it difficult to use a virtual reality headset
  • You have any medical or mental health condition that, in the opinion of the study doctor, would make it unsafe or difficult for you to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Jay L Alberts, PhD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MacKenzie Dunlap

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: All participants will complete all assessments and DBS conditions. They will first complete an ON medication/ON DBS session, followed by an OFF medication/OFF DBS session. The remaining 3 DBS testing conditions will be completed in a randomized order for each participant.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff

Study Record Dates

First Submitted

July 27, 2026

First Posted

August 6, 2026

Study Start (Estimated)

September 18, 2026

Primary Completion (Estimated)

March 18, 2027

Study Completion (Estimated)

April 18, 2027

Last Updated

August 6, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations